Vision Care Plus - Medicare Optometrist in Albion, MI

Vision Care Plus is a medicare enrolled "Optometrist" provider in Albion, Michigan. Their current practice location is 114 W Erie St, Albion, Michigan. You can reach out to their office (for appointments etc.) via phone at (517) 629-3981.

Vision Care Plus is licensed to practice in Michigan (license number 4901002927) and it also participates in the medicare program. Vision Care Plus is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1851486617.

Contact Information

Vision Care Plus
114 W Erie St,
Albion, MI 49224-1757
(517) 629-3981
(517) 629-3384



Healthcare Provider's Profile

Full NameVision Care Plus
TypeFacility
SpecialityOptometrist
Location114 W Erie St, Albion, Michigan
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1851486617
  • Provider Enumeration Date: 10/04/2006
  • Last Update Date: 02/28/2008
  Medicare PECOS Information:
  • PECOS PAC ID: 3072581966
  • Enrollment ID: O20040920000023

Medical Identifiers

Medical identifiers for Vision Care Plus such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1851486617NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4901002927 (Michigan)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vision Care Plus acts as a billing entity for following providers:
Provider NameSteven R Schaff
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1659488609
PECOS PAC ID: 6709854698
Enrollment ID: I20040922000044

News Archive

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

Male cyclists risk sexual problems if they don't choose the right bike

Men who take up cycling in an effort to stay fit, do their bit for the environment or avoid spiralling motoring costs, could be harming their health if they don't choose the right bicycle.

3 or more alcoholic drinks increases risk of ischemic stroke by 45%

A new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard School of Public Health (HSPH) has found that heavy drinkers - men who consume an average of three or more alcoholic beverages per day - are nearly 45 percent more likely to suffer an ischemic stroke compared with nondrinkers.

Read more Medical News

› Verified 1 days ago

Provider NameAnthony J Brechtelsbauer
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1760112973
PECOS PAC ID: 2365818283
Enrollment ID: I20221018002731

News Archive

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

Male cyclists risk sexual problems if they don't choose the right bike

Men who take up cycling in an effort to stay fit, do their bit for the environment or avoid spiralling motoring costs, could be harming their health if they don't choose the right bicycle.

3 or more alcoholic drinks increases risk of ischemic stroke by 45%

A new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard School of Public Health (HSPH) has found that heavy drinkers - men who consume an average of three or more alcoholic beverages per day - are nearly 45 percent more likely to suffer an ischemic stroke compared with nondrinkers.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Vision Care Plus is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vision Care Plus
2700 Wildwood Ave,
Jackson, MI 49202-3933

Ph: (517) 789-8119
Vision Care Plus
114 W Erie St,
Albion, MI 49224-1757

Ph: (517) 629-3981

News Archive

FDA authorizes Juventas' JVS-100 Phase II clinical trial for critical limb ischemia

Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that the U.S. Food and Drug Administration (FDA) authorized commencement of a Phase II clinical trial evaluating the efficacy and safety of its lead product, JVS-100, for the treatment of critical limb ischemia (CLI).

Russian researchers develop novel combined action drug for cancer diagnostics and treatment

Russian researchers announced the development of a combined action drug based on ionizing radiation and bacterial toxin. Their total effect appeared to be 2,200 times stronger compared to that exerted by the radiation and toxin, separately.

Male cyclists risk sexual problems if they don't choose the right bike

Men who take up cycling in an effort to stay fit, do their bit for the environment or avoid spiralling motoring costs, could be harming their health if they don't choose the right bicycle.

3 or more alcoholic drinks increases risk of ischemic stroke by 45%

A new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) and the Harvard School of Public Health (HSPH) has found that heavy drinkers - men who consume an average of three or more alcoholic beverages per day - are nearly 45 percent more likely to suffer an ischemic stroke compared with nondrinkers.

Read more News

› Verified 1 days ago


Optometrist in Albion, MI


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.